Hims & Hers (HIMS) CLO Soleil Boughton Sells 25,111 Shares

What Happened
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), sold 25,111 shares on August 19, 2026 at $27.55 per share, generating proceeds of approximately $691,808. The Form 4 reports the transaction as a sale (S) executed in the open market or private sale.

Key Details

• Transaction date: 2026-08-19; Price: $27.55 per share; Shares sold: 25,111; Proceeds: ~$691,808.
• Filing date: 2026-08-20 (Form 4 filed the day after the trade).
• Shares owned after transaction: not disclosed on the provided Form 4 excerpt.
• Footnote: Sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
• No indication in the filing that this was a late report.

Context
Insider sales executed under 10b5-1 plans are pre-arranged and are often routine portfolio-management transactions rather than signals about company fundamentals. Purchases are generally more informative to investors than routine sales; this filing alone does not indicate a change in insider sentiment.